Mario Gabelli's FOLD Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 40,000 shares of Amicus Therapeutics, Inc. (FOLD) worth $578,400, representing 0.01% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Mario Gabelli has initiated a new position in FOLD, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Amicus Therapeutics (FOLD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amicus Therapeutics (FOLD) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +40,000 | New Buy | 40,000 | $14.46 |
Mario Gabelli's Amicus Therapeutics Investment FAQs
Mario Gabelli first purchased Amicus Therapeutics, Inc. (FOLD) in Q1 2026, acquiring 40,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Amicus Therapeutics, Inc. (FOLD) for 1 quarters since Q1 2026.
Mario Gabelli's largest addition to Amicus Therapeutics, Inc. (FOLD) was in Q1 2026, adding 40,000 shares worth $578,400.
According to the latest 13F filing for Q1 2026, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 40,000 shares of Amicus Therapeutics, Inc. (FOLD), valued at approximately $578,400.
As of the Q1 2026 filing, Amicus Therapeutics, Inc. (FOLD) represents approximately 0.01% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in Amicus Therapeutics, Inc. (FOLD) was 40,000 shares, as reported at the end of Q1 2026.